Breaking News Instant updates and real-time market news.

TEVA

Teva

$19.12

0.31 (1.65%)

07:05
02/13/19
02/13
07:05
02/13/19
07:05

Teva sees FY19 adjusted EPS $2.20-$2.50, consensus $2.81

Sees revenue $17B-$17.4B, consensus $17.93B.

  • 13

    Feb

TEVA Teva
$19.12

0.31 (1.65%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

CLI

Mack-Cali Realty

$21.37

0.25 (1.18%)

19:32
02/20/19
02/20
19:32
02/20/19
19:32
Earnings
Mack-Cali Realty reports Q4 FFO 45c, consensus 45c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CLI

Mack-Cali Realty

$21.37

0.25 (1.18%)

19:32
02/20/19
02/20
19:32
02/20/19
19:32
Recommendations
Mack-Cali Realty analyst commentary  »

Mack-Cali Realty reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EVA

Enviva

$28.75

-0.25 (-0.86%)

19:17
02/20/19
02/20
19:17
02/20/19
19:17
Earnings
Enviva Partners reports Q4 EPS 28c, consensus 34c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

UBER

Uber

$0.00

(0.00%)

19:09
02/20/19
02/20
19:09
02/20/19
19:09
Periodicals
Uber to lower food delivery fees in U.K., Ireland, FT reports »

Uber will lower fees for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$29.35

-0.23 (-0.78%)

, SRCI

SRC Energy

$4.59

0.12 (2.68%)

19:02
02/20/19
02/20
19:02
02/20/19
19:02
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Avis…

CAR

Avis Budget

$29.35

-0.23 (-0.78%)

SRCI

SRC Energy

$4.59

0.12 (2.68%)

ALB

Albemarle

$82.82

-0.305 (-0.37%)

CDE

Coeur Mining

$5.55

0.045 (0.82%)

PEGA

Pegasystems

$59.39

0.95 (1.63%)

JACK

Jack in the Box

$78.95

-2 (-2.47%)

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

GHDX

Genomic Health

$83.70

1.11 (1.34%)

NTES

NetEase

$232.66

3.11 (1.35%)

LOPE

Grand Canyon

$97.13

0.18 (0.19%)

SNPS

Synopsys

$102.98

1.08 (1.06%)

ET

Energy Transfer LP

$15.51

-0.13 (-0.83%)

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

NE

Noble Corp.

$3.32

0.17 (5.40%)

FL

Foot Locker

$60.00

0.12 (0.20%)

CBLK

Carbon Black

$16.47

0.13 (0.80%)

SPTN

SpartanNash

$21.98

-0.25 (-1.12%)

VIPS

Vipshop

$7.30

0.35 (5.04%)

FLS

Flowserve

$47.75

0.485 (1.03%)

EVTC

Evertec

$30.65

0.3 (0.99%)

CONE

CyrusOne

$57.19

-0.46 (-0.80%)

XEC

Cimarex Energy

$76.38

1.3 (1.73%)

XPER

Xperi

$23.18

0.36 (1.58%)

SM

SM Energy

$19.70

0.61 (3.20%)

A

Agilent

$78.56

1.08 (1.39%)

PI

Impinj

$19.30

1.39 (7.76%)

QEP

QEP Resources

$8.19

-0.08 (-0.97%)

NUVA

NuVasive

$55.47

-1.81 (-3.16%)

ICLR

Icon

$145.61

0.28 (0.19%)

NDSN

Nordson

$138.81

-0.42 (-0.30%)

SEDG

SolarEdge

$41.48

-1.87 (-4.31%)

RBBN

Ribbon Communications

$6.06

-0.08 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 03

    Mar

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 13

    Mar

  • 14

    Mar

  • 17

    Mar

  • 20

    Mar

  • 21

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 22

    May

  • 22

    May

  • 18

    Jun

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

VMI

Valmont

$139.23

1.56 (1.13%)

18:55
02/20/19
02/20
18:55
02/20/19
18:55
Earnings
Valmont sees FY19 EPS $8.10-$8.90, consensus $8.56 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VMI

Valmont

$139.23

1.56 (1.13%)

18:51
02/20/19
02/20
18:51
02/20/19
18:51
Earnings
Valmont reports Q4 adjusted EPS $1.87, consensus $1.90 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

, GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

18:46
02/20/19
02/20
18:46
02/20/19
18:46
Periodicals
Google acquires more office space in Austin, Texas, SVBJ reports »

Alphabet's Google is…

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

PAAS

Pan American Silver

$14.68

-0.4 (-2.65%)

18:37
02/20/19
02/20
18:37
02/20/19
18:37
Hot Stocks
Breaking Hot Stocks news story on Pan American Silver »

Pan American Silver sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 24

    Feb

  • 24

    Feb

PAAS

Pan American Silver

$14.68

-0.4 (-2.65%)

18:36
02/20/19
02/20
18:36
02/20/19
18:36
Earnings
Pan American Silver reports Q4 adjusted EPS (1c), consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 24

    Feb

  • 24

    Feb

ARGO

Argo Group

$69.17

0.15 (0.22%)

18:25
02/20/19
02/20
18:25
02/20/19
18:25
Hot Stocks
Argo Group raises quarterly dividend to 31c per share from 27c »

The cash dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$126.47

-0.23 (-0.18%)

18:23
02/20/19
02/20
18:23
02/20/19
18:23
Hot Stocks
SPDR Gold Shares holdings rise to 794.50MT from 792.45MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SP

SP Plus Corp.

$36.62

0.15 (0.41%)

18:20
02/20/19
02/20
18:20
02/20/19
18:20
Earnings
SP Plus Corp. sees FY19 EPS $2.56-$2.66, consensus $2.59 »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GM

General Motors

$39.96

0.43 (1.09%)

, VLKAY

Volkswagen

$0.00

(0.00%)

18:20
02/20/19
02/20
18:20
02/20/19
18:20
Periodicals
Austria's Kurz says Trump, EU far apart on auto tariffs, Bloomberg says »

Austrian Chancellor…

GM

General Motors

$39.96

0.43 (1.09%)

VLKAY

Volkswagen

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$8.94

0.115 (1.30%)

FCAU

Fiat Chrysler

$15.04

0.2 (1.35%)

HMC

Honda

$27.61

0.05 (0.18%)

TM

Toyota

$122.81

1.28 (1.05%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 04

    Mar

  • 27

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

SP

SP Plus Corp.

$36.62

0.15 (0.41%)

18:18
02/20/19
02/20
18:18
02/20/19
18:18
Earnings
SP Plus reports Q4 adjusted EPS 57c, consensus 48c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LBY

Libbey

$5.75

0.15 (2.68%)

18:14
02/20/19
02/20
18:14
02/20/19
18:14
Earnings
Libbey sees FY19 revenue increase in low single digits, one estimate $806.6M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LBY

Libbey

$5.75

0.15 (2.68%)

18:13
02/20/19
02/20
18:13
02/20/19
18:13
Earnings
Libbey reports Q4 EPS (18c), two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:07
02/20/19
02/20
18:07
02/20/19
18:07
Hot Stocks
NetEase reports Q4 online game service revenues up 37.7% at $1.6B »

Reports Q4 e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:05
02/20/19
02/20
18:05
02/20/19
18:05
Hot Stocks
NetEase declares Q4 quarterly dividend of 48c vs 45c in Q3 »

The dividend is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Earnings
NetEase reports Q4 EPS $2.66, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LEE

Lee Enterprises

$2.61

0.01 (0.38%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Hot Stocks
Lee Enterprises board approves $10M stock repurchase program »

Lee Enterprises announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$13.48

-0.01 (-0.07%)

18:03
02/20/19
02/20
18:03
02/20/19
18:03
Hot Stocks
Kearny Financial raises quarterly dividend to 6c per share from 5c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Earnings
Breaking Earnings news story on Copart »

Copart reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

CE

Celanese

$102.65

1.71 (1.69%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Hot Stocks
Celanese raises Acetyl Intermediates price by 5c per lb »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:01
02/20/19
02/20
18:01
02/20/19
18:01
Earnings
Copart reports Q2 EPS 55c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.